Skip to content
‹ Back to IndustriesSciences

Material Signs: Introduction to the World of Optics

The experts discuss the impact of optics on modern technology and its pervasive role in industries ranging from consumer electronics to climate change mitigation. They highlight the advancements in optics technology over recent decades and its potential to address global challenges like improving internet access in impoverished regions.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Climate ChangeEnproMaterial SignsMonroe Community College
Share
Material Signs: Introduction to the World of Optics

Key takeaways

01

Optics touches nearly every aspect of modern life, from everyday technology to critical global challenges.

02

Advancements in optics over the last two decades have enabled the creation of smaller, lighter, and more precise optical systems.

03

The potential of optics includes providing global Wi-Fi access, even in underdeveloped regions.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Doctors Scott Carney, chief science and technology officer at Optica, Kate Medicus, CEO at Ruda-Cardinal, and Alexis Vogt, endowed chair and professor of optics at Monroe Community College, joined Host Tyler Kern for the very first podcast of Enpro’s Material Signs to talk about the world of optics and its impact on the world.

Optics, which is the science of light, is arguably the oldest science with its roots going back to 2,500 years ago with the law of reflection. Now, optics likely touches every aspect of modern life, expanding into many technologies, such as lasers, cell phones, computer chips, cameras, cars, and even champagne inspection machines.

It also is a big factor in helping solve bigger needs, like fighting global climate change, enabling space exploration, and assisting national security measures. Carney summed it up perfectly, saying: “I think it would be easier to identify the things that you interact with that don’t involve optics.”

Optics is prominent in nearly all industries and touches many different businesses. What excites Vogt the most about the endless opportunities is the ability to help impoverished areas. She explained, “Think about the technologies that are forthcoming … like having Wi-Fi access to all people around the entire world — even to developing countries that don’t have running water.”

Medicus expanded on how far the technology has come in just two short decades: “Over the last twenty years … we can manufacture the most oddly shaped glass elements, which allows us to have smaller optical systems, lighter-weight optical systems — or more precise optical systems — and that allows us to grow the technology and grow our innovation.”

Optics is changing the way people live, and each person, company, product, and technology plays a huge role in making that revolution happen.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

S
Sciences
SC
Scott Carney

Chief Science and Technology Officer

Optica

KM
Kate Medicus

CEO

Ruda-Cardinal

AV
Alexis Vogt

Endowed Chair and Professor of Optics

Monroe Community College

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512